IRLAB to present at ABGSC Investor Days on November 22, 2023

Gothenburg, Sweden, November 20, 2023 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today announced that the company will present at the ABGSC Investor Days on Wednesday, November 22, 2023, in Stockholm, Sweden.

Gunnar Olsson, CEO, and Nicholas Waters, EVP and Head of R&D, will participate in the event. The company will be presented at 14:00-14:30 CET on November 22, 2023. This event is held at Hotel At Six, Brunkebergstorg 6, Stockholm, and is live-streamed.

More information can be found on the event webpage at: https://cr.abgsc.com/artiklar/2023/10/abgsc-investor-days-22-23-november/

Datum 2023-11-20, kl 07:00
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!